BriaCell Therapeutics Corp. (BCTX): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$28.65M
Year ended 2026-07-31
2021-07-31: -$7.75M2022-07-31: -$12.48M2023-07-31: -$23.74M2024-07-31: -$24.13M2025-07-31: -$28.17M2026-07-31: -$28.65M-$28.65M
2021-07-31 Operating Cash Flow (USD) 2026-07-31
Period endedOperating Cash FlowChange YoYSource filing
2026-07-31-$28.65Mn/m2026-10-28, From 2025-08-01
2025-07-31-$28.17Mn/m2026-10-28, From 2024-08-01
2024-07-31-$24.13Mn/m2025-10-16, From 2023-08-01
2023-07-31-$23.74Mn/m2024-10-29, From 2022-08-01
2022-07-31-$12.48Mn/m2023-10-25, From 2021-08-01
2021-07-31-$7.75Mn/a2022-10-28, From 2020-08-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
BriaCell Therapeutics Corp. (BCTX)2026-07-31-$28.65Mn/m
Immunic, Inc. (IMUX)2025-12-31-$85.81Mn/m
Rein Therapeutics, Inc. (RNTX)2025-12-31-$19.36Mn/m
Kiora Pharmaceuticals Inc (KPRX)2025-12-31-$9.96Mn/m
Faeth Therapeutics, Inc. (FTH)2025-12-31-$20.45Mn/m
CervoMed Inc. (CRVO)2025-12-31-$23.45Mn/m
Gain Therapeutics, Inc. (GANX)2025-12-31-$18.47Mn/m
HCW Biologics Inc. (HCWB)2025-12-31-$13.39Mn/m
Onconetix, Inc. (ONCO)2025-12-31-$9.68Mn/m

Compare BCTX, IMUX, RNTX, KPRX side by side · Screen every company in Pharmaceutical Preparations ↗